GNH USA

Europe — EMA

Novofen (Tamoxifen)

GNH USA supplies Novofen (Tamoxifen), a selective estrogen receptor modulator for estrogen receptor‑positive breast cancer treatment and recurrence

Tamoxifen

Request sourcing

1
Pack/s

What is Tamoxifen?

Tamoxifen, the active ingredient in Novofen, is a selective estrogen receptor modulator (SERM) presented as an oral tablet for oral use. It is used to treat estrogen receptor‑positive breast cancer in women, both as adjuvant therapy and for recurrence prevention.

GNH USA supplies Novofen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Tamoxifen used for?

Novofen (tamoxifen) acts on estrogen‑driven breast cancer pathways and is employed in several clinical settings.

- Estrogen receptor‑positive breast cancer: used as adjuvant therapy to lower the risk of disease recurrence after surgery. - Breast cancer recurrence prevention: administered to reduce the chance of cancer returning in patients who have completed primary treatment. - High‑risk women (e.g., strong family history or genetic predisposition): given prophylactically to decrease the incidence of developing breast cancer.

What are the side effects of Tamoxifen?

Common side effects are generally mild to moderate and may affect daily comfort.

Common Side Effects: - Hot flashes: sudden feeling of warmth and sweating. - Nausea: mild to moderate stomach upset. - Menstrual irregularities: changes in cycle length or flow. - Fatigue: persistent tiredness.

Serious or Rare Side Effects: - Deep vein thrombosis or pulmonary embolism: blood clots in veins or lungs. - Endometrial cancer: abnormal growth of the uterine lining. - Severe liver injury: jaundice, elevated enzymes. - Stroke or cerebrovascular events: neurological deficits due to impaired blood flow.

What precautions apply to Tamoxifen?

Before initiating therapy, several safety considerations should be addressed.

- Pregnancy risk: avoid use in pregnant women; tamoxifen is Category D. - Thromboembolic history: assess for prior clotting disorders. - Uterine health: monitor for abnormal uterine bleeding. - Liver function: evaluate baseline hepatic enzymes. - Store at room temperature: keep in the original container, protect from moisture and heat.

What does Tamoxifen interact with?

Tamoxifen may interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Strong CYP2D6 inhibitors (e.g., paroxetine, fluoxetine): may reduce active metabolite formation. - Anticoagulants (e.g., warfarin): increased risk of bleeding.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): may lower tamoxifen exposure. - Hormone replacement therapy or estrogen‑containing contraceptives: may counteract anti‑estrogen effect. - Certain SSRIs with moderate CYP2D6 inhibition (e.g., sertraline): monitor therapeutic response.

Frequently asked questions

What is Novofen used for?+
Novofen contains tamoxifen, a selective estrogen receptor modulator that is prescribed for estrogen receptor‑positive breast cancer. It is used as adjuvant therapy after surgery, to prevent disease recurrence, and as a prophylactic option for women at high risk of developing breast cancer.
How does tamoxifen work?+
Tamoxifen binds to estrogen receptors in breast tissue, acting as an antagonist that blocks estrogen‑driven cell growth. In bone and uterine tissue it shows partial agonist activity, preserving bone density while still inhibiting tumor proliferation. Its active metabolites, produced mainly by CYP2D6, sustain this anti‑estrogenic effect.
What is the usual dose of Novofen?+
The specific dose of Novofen is determined by the prescribing clinician based on the individual’s medical condition, treatment stage, and response. Standard dosing regimens for tamoxifen exist, but the exact amount and schedule should be set by a qualified healthcare professional.
Is Novofen safe in pregnancy or breastfeeding?+
Novofen is classified as Pregnancy Category D, indicating evidence of risk to the fetus. It should not be used during pregnancy, and women of child‑bearing potential must use effective contraception. Breastfeeding is not recommended while taking tamoxifen because the drug can pass into milk.
How do I order Novofen from GNH USA?+
To order Novofen, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Novofen compare with the main alternative drug or class?+
The primary alternative to tamoxifen is the class of aromatase inhibitors, which lower estrogen production rather than blocking its receptor. Aromatase inhibitors are often used in post‑menopausal women, whereas tamoxifen is effective in both pre‑ and post‑menopausal patients and also offers bone‑protective benefits.
How should Novofen be stored and handled?+
Novofen tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and excessive heat. Keep the container tightly closed and out of direct sunlight to maintain product stability.
How is Novofen administered?+
Novofen is taken orally as a tablet, usually with a glass of water. It can be taken with or without food, but consistency with meals may help reduce gastrointestinal upset. Patients should follow the dosing schedule prescribed by their healthcare provider.
What are the most serious risks to watch for while taking Novofen?+
Serious risks include blood clots such as deep vein thrombosis or pulmonary embolism, endometrial cancer, severe liver injury, and cerebrovascular events like stroke. Patients should promptly report symptoms such as unexplained leg swelling, abnormal uterine bleeding, jaundice, or sudden neurological changes.
Who should not use Novofen?+
Novofen should not be used by pregnant women, individuals with a known history of thromboembolic disease, patients with active or past endometrial cancer, and those with severe liver impairment. Contra‑indications are determined by the prescribing clinician based on the patient’s overall health profile.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Tamoxifen
Route
Oral Use
Manufacturer
Remedica Ltd
Origin
EU

Related products

Adifen

Adifen

Tamoxifen

Medicamerc Pharmaceuticals S.A
EU
Ebefen

Ebefen

Tamoxifen

Ebewe Pharma
EU
Nolvadex

Nolvadex

Tamoxifen

Astrazeneca Oesterreich Gmbh
EU
Novofen

Novofen

Tamoxifen

Remedica Ltd
EU